GLORIA MELANIE (Chief Operating Officer) sold 1.4% of their position (3.06K shares) of IMMUNOVANT, INC. on the open market
Open‑market sale worth $135.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/21/2026ACC: 0001973838-26-000007
Officer· Chief Operating Officer
Since Feb 2026
-3.06K
Net shares
Net seller
$135.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.06K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.06K
Price / share
$44.16
Trade value
$134.95K
% of position
1.4%
8/20/2026
222.36K→219.30K
Total
Net shares
−3.06K
Net value
-$134.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/20/2026 | S · Sale | −3.06K | $44.16 | $134.95K | 1.4% | 222.36K | 219.30K |
| Total | −3.06K | -$134.95K | ||||||
Derivative Transactions0
No derivative transactions reported